Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 3
1963 2
1964 2
1965 1
1966 8
1967 4
1969 1
1970 3
1971 5
1974 1
1977 1
1978 7
1979 2
1980 4
1981 6
1982 3
1983 4
1984 2
1985 4
1986 8
1987 2
1988 8
1989 7
1990 5
1991 3
1992 7
1993 6
1994 4
1995 10
1996 10
1997 6
1998 12
1999 23
2000 19
2001 24
2002 16
2003 22
2004 20
2005 34
2006 22
2007 17
2008 22
2009 17
2010 23
2011 26
2012 37
2013 37
2014 26
2015 36
2016 19
2017 27
2018 26
2019 27
2020 35
2021 40
2022 23
2023 30
2024 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

754 results

Results by year

Filters applied: . Clear all
Page 1
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sugiura I, Doki N, Hata T, Cho R, Ito T, Suehiro Y, Tanaka M, Kako S, Matsuda M, Yokoyama H, Ishikawa Y, Taniguchi Y, Hagihara M, Ozawa Y, Ueda Y, Hirano D, Sakura T, Tsuji M, Kamae T, Fujita H, Hiramoto N, Onoda M, Fujisawa S, Hatta Y, Dobashi N, Nishiwaki S, Atsuta Y, Kobayashi Y, Hayakawa F, Ohtake S, Naoe T, Miyazaki Y. Sugiura I, et al. Among authors: fujisawa s. Blood Adv. 2022 Jan 25;6(2):624-636. doi: 10.1182/bloodadvances.2021004607. Blood Adv. 2022. PMID: 34516628 Free PMC article. Clinical Trial.
Stability and function of regulatory T cells expressing the transcription factor T-bet.
Levine AG, Mendoza A, Hemmers S, Moltedo B, Niec RE, Schizas M, Hoyos BE, Putintseva EV, Chaudhry A, Dikiy S, Fujisawa S, Chudakov DM, Treuting PM, Rudensky AY. Levine AG, et al. Among authors: fujisawa s. Nature. 2017 Jun 15;546(7658):421-425. doi: 10.1038/nature22360. Epub 2017 Jun 7. Nature. 2017. PMID: 28607488 Free PMC article.
A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing.
Madisen L, Mao T, Koch H, Zhuo JM, Berenyi A, Fujisawa S, Hsu YW, Garcia AJ 3rd, Gu X, Zanella S, Kidney J, Gu H, Mao Y, Hooks BM, Boyden ES, Buzsáki G, Ramirez JM, Jones AR, Svoboda K, Han X, Turner EE, Zeng H. Madisen L, et al. Among authors: fujisawa s. Nat Neurosci. 2012 Mar 25;15(5):793-802. doi: 10.1038/nn.3078. Nat Neurosci. 2012. PMID: 22446880 Free PMC article.
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.
Calvo V, Zheng W, Adam-Artigues A, Staschke KA, Huang X, Cheung JF, Nobre AR, Fujisawa S, Liu D, Fumagalli M, Surguladze D, Stokes ME, Nowacek A, Mulvihill M, Farias EF, Aguirre-Ghiso JA. Calvo V, et al. Among authors: fujisawa s. Clin Cancer Res. 2023 Dec 15;29(24):5155-5172. doi: 10.1158/1078-0432.CCR-23-1427. Clin Cancer Res. 2023. PMID: 37982738 Free PMC article.
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.
Stokes ME, Calvo V, Fujisawa S, Dudgeon C, Huang S, Ballal N, Shen L, Gasparek J, Betzenhauser M, Taylor SJ, Staschke KA, Rigby AC, Mulvihill MJ, Bose N, Lightcap ES, Surguladze D. Stokes ME, et al. Among authors: fujisawa s. Clin Cancer Res. 2023 Dec 1;29(23):4870-4882. doi: 10.1158/1078-0432.CCR-23-1182. Clin Cancer Res. 2023. PMID: 37733811 Free PMC article.
Hippocampal ripples down-regulate synapses.
Norimoto H, Makino K, Gao M, Shikano Y, Okamoto K, Ishikawa T, Sasaki T, Hioki H, Fujisawa S, Ikegaya Y. Norimoto H, et al. Among authors: fujisawa s. Science. 2018 Mar 30;359(6383):1524-1527. doi: 10.1126/science.aao0702. Epub 2018 Feb 8. Science. 2018. PMID: 29439023
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, Kurahashi S, Ueda Y, Dobashi N, Maeda T, Matsumura I, Tanaka M, Kako S, Ichinohe T, Fukuda T, Ohtake S, Ishikawa Y, Miyazaki Y, Kiyoi H; Japan Adult Leukemia Study Group. Nishiwaki S, et al. Among authors: fujisawa s. Am J Hematol. 2024 May;99(5):806-815. doi: 10.1002/ajh.27237. Epub 2024 Feb 5. Am J Hematol. 2024. PMID: 38314662
754 results